Medpace Holdings, Inc. MEDP

MEDP Company Overview

Medpace Holdings, Inc. is a U.S.-based clinical contract research organization (CRO) that provides outsourced clinical development services to biotechnology, pharmaceutical, and medical device companies. The company operates within the global life sciences and healthcare research industries, supporting clients through the design, management, and execution of clinical trials across multiple therapeutic areas. Medpace’s services span early-phase development through post-marketing clinical support, with a business model centered on providing integrated, full-service clinical research capabilities.

The company’s primary revenue drivers come from its clinical trial management services, including project management, regulatory affairs, clinical monitoring, data management, biostatistics, pharmacovigilance, and laboratory services. Medpace is particularly active in oncology, cardiology, metabolic diseases, anti-viral and anti-infective therapies, central nervous system disorders, and medical device studies. The company was founded in 1992 by Dr. August Troendle and expanded from a niche CRO into a globally integrated organization serving emerging biotechnology firms as well as larger pharmaceutical sponsors. Its strategic positioning is often associated with its full-service model, therapeutic specialization, and operational control through internally managed laboratories and technology systems.